(Q33607445)

28 July 2017

1 reference

title

Hepatorenal syndrome and ascites--an introduction (English)

1 reference

28 July 2017

1 reference

Gentilini P

1

1 reference

28 July 2017

1 January 1999

1 reference

28 July 2017

1 reference

28 July 2017

19

1 reference

28 July 2017

1 Suppl

1 reference

28 July 2017

5-14

1 reference

The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus

28 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Renal sodium retention during upright posture in preascitic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Pathophysiology and treatment of ascites and the hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Cirrhotic ascites. Pathophysiology, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00091.X

10.1111/J.1478-3231.1999.TB00091.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10226999